The interaction of some centrally active drugs with the blood-brain barrier and circumventricular organs

Progress in Brain Research

Volumn 91, Issue C, 1992, Pages 163-169

  Begley, David J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; OCTREOTIDE; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD BRAIN BARRIER; CONFERENCE PAPER; CONTROLLED STUDY; GUINEA PIG; NONHUMAN;

EID: 0026655842     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)62331-6     Document Type: Article

References (33)

1. Bauer, W., Briner, U., Doepfner, W., Hall, R., Huguenin, R., Marbach, P., Pethcher, T.J., Pless, J., SMS 201–995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31 (1982), 1133–1141.
2. Begley, D.J., Squires, L.K., Zloković, C.W., Mitrović, B.V., Hughes, D.M., Revest, P.A., Greenwood, J., Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J. Neurochem. 55 (1990), 1222–1230.
3. Blasberg, R.G., Fenstermacher, J.D., Patlak, C.S., Transport of α-aminoisobutyric acid across the brain capillary and cellular membranes. J. Cereb. Blood Flow Metab. 3 (1983), 8–32.
4. Borel, J.F., Feuer, C., Magnée, C., Stähelin, H., Effects of the new antilymphocytic peptide cyclosporin A in animals. Immunology 32 (1977), 1017–1025.
5. Cordon-Cardo, C., O'Brien, J.P., Casals, D., Rittman-Grauer, L., Biedler, J.L., Melamed, M.R., Bertino, J.R., Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. U.S.A. 86 (1989), 695–698.
6. Creasey, W.A., Vinca alkaloids and colchicine. Sartorelli, A.C., Johns, D.G., (eds.) Antineoplastic and Immunosuppressive Agents II, 1975, Springer, Berlin, 670–694.
7. El Dareer, S.M., White, V.M., Chen, F.P., Mellett, L.B., Hill, D.L., Distribution and metabolism of vincristine in mice, rats, dogs and monkeys. Cancer Treat. Rep. 61 (1977), 1269–1277.
8. Endicott, J.A., Ling, V., The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58 (1989), 137–171.
9. Fenstermacher, J.D., Pharmacology of the blood-brain barrier. Neuwelt, E.A., (eds.) Implications of the Blood-Brain Barrier and its Manipulation. Volume I. Basic Science Aspects, 1989, Plenum, New York, 137–155.
10. Fenstermacher, J.D., Rapoport, S.I., Blood-brain barrier. Renkin, E.M., Michel, C.C., (eds.) Handbook of Physiology, Section II. The Cardiovascular System., IV, 1984, American Physiological Society, 969–1000 Microcirculation, Part 2.
11. Fenstermacher, J.D., Gross, P., Sposito, N., Pettersen, S., Gruber, K., Structural and functional variations in capillary systems within the brain. Ann. N.Y. Acad. Sci. 529 (1988), 21–30.
12. Ford, J.M., Hait, W.N., Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42 (1990), 155–198.
13. Gjedde, A., Rasmussen, M., Blood-brain glucose transport in the conscious rat: comparison of intravenous and intracarotid injection methods. J. Neurochem. 35 (1980), 1375–1381.
14. Go, K.G., Pratt, J.J., The dependence of the blood to brain passage of radioactive sodium on blood pressure and temperature. Brain Res. 93 (1975), 329–336.
15. Jackson, D.V. Jr., Sethi, V.S., Spurr, C.L., McWhorter, J.M., Pharmacokinetics of vincristine in the cerebrospinal fluid of humans. Cancer Res. 41 (1981), 1466–1468.
16. Krenning, E.P., Breeman, W.A.P., Kooij, P.P.M., Lameris, J.S., Bakker, W.H., Koper, J.W., Ausema, L., Reubi, J.C., Lamberts, S.W.J., Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet i (1989), 242–243.
17. Lamberts, S.W.J., Non-pituitary actions of somatostatin. A review on the therapeutic role of SMS 201–995 (Sandostatin). Acta Endocrinol. 112 (1986), 41–45 Suppl. 276.
18. Lamberts, S.W.J., A guide to the clinical use of the somatostatin analogue SMS 201–995 (Sandostatin). Acta Endocrinol. 116 (1987), 54–66 Suppl. 286.
19. Lemaire, M., Tillement, J.P., Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood. J. Pharm. Pharmacol. 34 (1982), 715–718.
20. Lemaire, M., Pardridge, W.M., Chaudhuri, G., Influence of blood components on the tissue uptake indices of cyclosporin in rats. J. Pharmacol. Exp. Ther. 244 (1988), 740–743.
21. Levin, V.A., Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem. 23 (1980), 682–684.
22. MacLeod, R.M., Judd, A.M., Jarvis, W.D., Login, I.S., Non-pituitary actions of hypothalamic hormones functional significance and therapeutic implications. Acta Endocrinol. 112 (1986), 9–20 Suppl. 276.
23. Moscow, J.A., Cowan, K.H., Multidrug resistance. J. Natl. Can. Inst. 80 (1988), 14–20.
24. Ohno, K., Pettigrew, K.D., Rapoport, S.I., Lower limits of cerebrovascular permeability to non electrolytes in the conscious rat. Am. J. Physiol. 235 (1978), H229–H307.
25. Oldendorf, W.H., Lipid solubility and drug penetration of the blood-brain barrier. Proc. Soc. Exp. Biol. Med. 147 (1974), 813–816.
26. Palestine, A.G., Nussenblatt, R.B., Chan, C-C., Cyclosporin penetration into the anterior chamber and cerebrospinal fluid. Am. J. Opthalmol. 99 (1985), 210–211.
27. Pless, J., Chemical structure-pharmacological profile of Sandostatin. Dorisio, T.M., (eds.) Sandostatin in the Treatment of Gastroenteropancreatic Endocrine Tumors, 1989, Springer, Berlin, 3–13.
28. Rapoport, S.I., Ohno, K., Pettigrew, K.D., Drug entry into brain. Brain Res. 172 (1979), 354–359.
29. Rapoport, S.I., Fredericks, W.R., Ohno, K., Pettigrew, K.D., Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Am. J. Physiol. 238 (1980), R421–R431.
30. Reubi, J.C., Lang, W., Maurer, R., Koper, J.W., Lamberts, S.W.J., Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res. 47 (1987), 5758–5764.
31. Reubi, J.C., Lamberts, S.W.J., Maurer, R., Somatostatin receptors in normal and tumoral tissue. Hormone Res. 29 (1988), 65–69.
32. Twentyman, P.R., Fox, N.E., White, D.J.G., Cyclosporin A and it analogues as modifiers of adriamycin and vincristine resistance in a multidrug resistant human lung cancer cell line. Br. J. Cancer, 56, 1987, 55.
33. Ziylan, Y.Z., LeFauconnier, J.M., Bernard, G., Bourre, J.M., Effects of dexamethasone on transport of α-aminoisobutyric acid and sucrose across the blood-brain barrier. J. Neurochem. 51 (1988), 1338–1342.